HCP
NEO icon

Hexagon Capital Partners’s NeoGenomics NEO Stock Holding History

Hexagon Capital Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25
Closed -$237 – 1117
2025
Q1 		$237 Buy
+25
New +$312 ﹤0.01% 1739

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hexagon Capital Partners's NEO Position: Q2 2025 in Review

Hexagon Capital Partners sold out of NeoGenomics (NEO) in Q2 2025, closing a stake of 25 shares — an estimated $237 sold.

Hexagon Capital Partners first reported a position in NEO in Q1 2025 and held it in 1 quarter. The position peaked at $237 in Q1 2025. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

  • Hexagon Capital Partners reported no remaining NeoGenomics position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 25 NeoGenomics shares in Q2 2025, an estimated $237.
  • Hexagon Capital Partners first reported a position in NeoGenomics in Q1 2025 and held it in 1 quarter.
  • Hexagon Capital Partners's NeoGenomics position peaked at $237 in Q1 2025.
  • 274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.